To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information

I Agree

Chemiluminescence Immunoassay (CLIA) Analyzers Market

Chemiluminescence Immunoassay (CLIA) Analyzers Market Analysis, By Product (Analyzers, Reagents, Consumables), By Application (Endocrine Disorders, Oncology, Infectious Diseases, Hepatitis & Retrovirus, Cardiovascular Disorders, Others), By End User & Region – Global Market Insights 2023-2033

Analysis of Chemiluminescence Immunoassay (CLIA) Analyzers Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Request FREE Sample
Request FREE Customization

Table of Content

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

            4.3.1.1. Ultrasensitive method with wider dynamic range of tests

            4.3.1.2. Growing demand for international accreditations and result comparability using high throughput automated immunoassays

        4.3.2. Restraints

            4.3.2.1. Availability of alternative diagnostic test at relatively lower cost

            4.3.2.2. Fragmented consumables market affecting profit margin

        4.3.3. Opportunity

    4.4. Global Market Analysis and Forecasts, 2023–2033

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Market Outlook

    4.6. Disease Prevalence & Incidence Rate globally with key countries

    4.7. Technological Advancements

    4.8. Top 3 players operating in the market space

    4.9. Healthcare Industry Overview

5. Global Market Analysis and Forecasts, By Product Type

    5.1. Introduction & Definition

    5.2. Key Findings / Developments

    5.3. Market Value Forecast By Product Type, 2023–2033

        5.3.1. Analyzers

            5.3.1.1. Automated

            5.3.1.2. Semi-automated

        5.3.2. Reagents

            5.3.2.1. Luminophore Markers

            5.3.2.2. Enzymatic Markers

        5.3.3. Consumables

    5.4. Market Attractiveness By Product Type

6. Global Market Analysis and Forecasts, By Application

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast By Application, 2023–2033

        6.3.1. Endocrine Disorders

        6.3.2. Oncology

        6.3.3. Infectious Diseases

        6.3.4. Hepatitis and Retrovirus

        6.3.5. Cardiovascular Disorders

        6.3.6. Allergy

        6.3.7. Autoimmunity

        6.3.8. Drug Discovery and Development

        6.3.9. Others

    6.4. Market Attractiveness By Application

7. Global Market Analysis and Forecasts, By End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast By End-user, 2023–2033

        7.3.1. Hospitals

        7.3.2. Clinical Laboratories

        7.3.3. Pharmaceutical & Biotechnology Industries

        7.3.4. Others

    7.4. Market Attractiveness By End-user

8. Global Market Analysis and Forecasts, By Region

    8.1. Key Findings

    8.2. Market Value Forecast By Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness By Country/Region

9. North America Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast By Product Type, 2023–2033

        9.2.1. Analyzers

            9.2.1.1. Automated

            9.2.1.2. Semi-automated

        9.2.2. Reagents

            9.2.2.1. Luminophore Markers

            9.2.2.2. Enzymatic Markers

        9.2.3. Consumables

    9.3. Market Value Forecast By Application, 2023–2033

        9.3.1. Endocrine Disorders

        9.3.2. Oncology

        9.3.3. Infectious Diseases

        9.3.4. Hepatitis and Retrovirus

        9.3.5. Cardiovascular Disorders

        9.3.6. Allergy

        9.3.7. Autoimmunity

        9.3.8. Drug Discovery and Development

        9.3.9. Others

    9.4. Market Value Forecast By End-user, 2023–2033

        9.4.1. Hospitals

        9.4.2. Clinical Laboratories

        9.4.3. Pharmaceutical & Biotechnology Industries

        9.4.4. Others

    9.5. Market Value Forecast By Country, 2023–2033

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. By Product Type

        9.6.2. By Application

        9.6.3. By End-user

        9.6.4. By Country

10. Europe Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast By Product Type, 2023–2033

        10.2.1. Analyzers

            10.2.1.1. Automated

            10.2.1.2. Semi-automated

        10.2.2. Reagents

            10.2.2.1. Luminophore Markers

            10.2.2.2. Enzymatic Markers

        10.2.3. Consumables

    10.3. Market Value Forecast By Application, 2023–2033

        10.3.1. Endocrine Disorders

        10.3.2. Oncology

        10.3.3. Infectious Diseases

        10.3.4. Hepatitis and Retrovirus

        10.3.5. Cardiovascular Disorders

        10.3.6. Allergy

        10.3.7. Autoimmunity

        10.3.8. Drug Discovery and Development

        10.3.9. Others

    10.4. Market Value Forecast By End-user, 2023–2033

        10.4.1. Hospitals

        10.4.2. Clinical Laboratories

        10.4.3. Pharmaceutical & Biotechnology Industries

        10.4.4. Others

    10.5. Market Value Forecast By Country/Sub-region, 2023–2033

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. By Product Type

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country/Sub-region

11. Asia Pacific Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast By Product Type, 2023–2033

        11.2.1. Analyzers

            11.2.1.1. Automated

            11.2.1.2. Semi-automated

        11.2.2. Reagents

            11.2.2.1. Luminophore Markers

            11.2.2.2. Enzymatic Markers

        11.2.3. Consumables

    11.3. Market Value Forecast By Application, 2023–2033

        11.3.1. Endocrine Disorders

        11.3.2. Oncology

        11.3.3. Infectious Diseases

        11.3.4. Hepatitis and Retrovirus

        11.3.5. Cardiovascular Disorders

        11.3.6. Allergy

        11.3.7. Autoimmunity

        11.3.8. Drug Discovery and Development

        11.3.9. Others

    11.4. Market Value Forecast By End-user, 2023–2033

        11.4.1. Hospitals

        11.4.2. Clinical Laboratories

        11.4.3. Pharmaceutical & Biotechnology Industries

        11.4.4. Others

    11.5. Market Value Forecast By Country/Sub-region, 2023–2033

        11.5.1. China

        11.5.2. Japan

        11.5.3. India

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Market Attractiveness Analysis

        11.6.1. By Product Type

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Latin America Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast By Product Type, 2023–2033

        12.2.1. Analyzers

            12.2.1.1. Automated

            12.2.1.2. Semi-automated

        12.2.2. Reagents

            12.2.2.1. Luminophore Markers

            12.2.2.2. Enzymatic Markers

        12.2.3. Consumables

    12.3. Market Value Forecast By Application, 2023–2033

        12.3.1. Endocrine Disorders

        12.3.2. Oncology

        12.3.3. Infectious Diseases

        12.3.4. Hepatitis and Retrovirus

        12.3.5. Cardiovascular Disorders

        12.3.6. Allergy

        12.3.7. Autoimmunity

        12.3.8. Drug Discovery and Development

        12.3.9. Others

    12.4. Market Value Forecast By End-user, 2023–2033

        12.4.1. Hospitals

        12.4.2. Clinical Laboratories

        12.4.3. Pharmaceutical & Biotechnology Industries

        12.4.4. Others

    12.5. Market Value Forecast By Country/Sub-region, 2023–2033

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis

        12.6.1. By Product Type

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Middle East & Africa Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast By Product Type, 2023–2033

        13.2.1. Analyzers

            13.2.1.1. Automated

            13.2.1.2. Semi-automated

        13.2.2. Reagents

            13.2.2.1. Luminophore Markers

            13.2.2.2. Enzymatic Markers

        13.2.3. Consumables

    13.3. Market Value Forecast By Application, 2023–2033

        13.3.1. Endocrine Disorders

        13.3.2. Oncology

        13.3.3. Infectious Diseases

        13.3.4. Hepatitis and Retrovirus

        13.3.5. Cardiovascular Disorders

        13.3.6. Allergy

        13.3.7. Autoimmunity

        13.3.8. Drug Discovery and Development

        13.3.9. Others

    13.4. Market Value Forecast By End-user, 2023–2033

        13.4.1. Hospitals

        13.4.2. Clinical Laboratories

        13.4.3. Pharmaceutical & Biotechnology Industries

        13.4.4. Others

    13.5. Market Value Forecast By Country/Sub-region, 2023–2033

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Israel

        13.5.4. Rest of Middle East & Africa

    13.6. Market Attractiveness Analysis

        13.6.1. By Product Type

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Market Share Analysis By Company (2022)

    14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

        14.3.1. Abbott

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. SWOT Analysis

            14.3.1.5. Strategic Overview

        14.3.2. F. Hoffmann-La Roche Ltd

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. SWOT Analysis

            14.3.2.5. Strategic Overview

        14.3.3. Siemens Healthcare GmbH (Siemens AG)

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. SWOT Analysis

            14.3.3.5. Strategic Overview

        14.3.4. Danaher (Beckman Coulter, Inc.)

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.4.2. Financial Overview

            14.3.4.3. Product Portfolio

            14.3.4.4. SWOT Analysis

            14.3.4.5. Strategic Overview

        14.3.5. DiaSorin S.p.A.

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. SWOT Analysis

            14.3.5.5. Strategic Overview

        14.3.6. Ortho Clinical Diagnostics (Part of Carlyle Group)

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. SWOT Analysis

            14.3.6.5. Strategic Overview

        14.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. SWOT Analysis

            14.3.7.5. Strategic Overview

        14.3.8. Sysmex Corporation

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. SWOT Analysis

            14.3.8.5. Strategic Overview

        14.3.9. Randox Laboratories Ltd.

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. SWOT Analysis

            14.3.9.5. Strategic Overview

        14.3.10. Tosoh Corporation

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strengths)

            14.3.10.2. Financial Overview

            14.3.10.3. Product Portfolio

            14.3.10.4. SWOT Analysis

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 01: Global Market Value (US$ Mn) Forecast, by Product, 2023–2033

Table 02: Global Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033

Table 03: Global Market Value (US$ Mn) Forecast, by Reagents, 2023–2033

Table 04: Global Market Value (US$ Mn) Forecast, by Application, 2023–2033

Table 05: Global Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 06: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033

Table 07: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033

Table 08: North America Market Value (US$ Mn) Forecast, by Product, 2023–2033

Table 09: North America Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033

Table 10: North America Market Value (US$ Mn) Forecast, by Reagents, 2023–2033

Table 11: North America Market Value (US$ Mn) Forecast, by Application, 2023–2033

Table 12: North America Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 13: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 14: Europe Market Value (US$ Mn) Forecast, by Product, 2023–2033

Table 15: Europe Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033

Table 16: Europe Market Value (US$ Mn) Forecast, by Reagents, 2023–2033

Table 17: Europe Market Value (US$ Mn) Forecast, by Application, 2023–2033

Table 18: Europe Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 19: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 20: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2023–2033

Table 21: Asia Pacific Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033

Table 22: Asia Pacific Market Value (US$ Mn) Forecast, by Reagents, 2023–2033

Table 23: Asia Pacific Market Value (US$ Mn) Forecast, by Application, 2023–2033

Table 24: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 25: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 26: Latin America Market Value (US$ Mn) Forecast, by Product, 2023–2033

Table 27: Latin America Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033

Table 28: Latin America Market Value (US$ Mn) Forecast, by Reagents, 2023–2033

Table 29: Latin America Market Value (US$ Mn) Forecast, by Application, 2023–2033

Table 30: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023–2033

Table 31: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023–2033

Table 32: Middle East & Africa Market Value (US$ Mn) Forecast, by Product, 2023–2033

Table 33: Middle East & Africa Market Value (US$ Mn) Forecast, by Analyzers, 2023–2033

Table 34: Middle East & Africa Market Value (US$ Mn) Forecast, by Reagents, 2023–2033

Table 35: Middle East & Africa Market Value (US$ Mn) Forecast, by Application, 2023–2033

Table 36: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2023–2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2033

Figure 02: Global Market Value (US$ Mn) Forecast, 2023–2033

Figure 03: Global Market Value Share, by Product (2022)

Figure 04: Global Market Value Share, by Application (2022)

Figure 05: Global Market Value Share, by End-user (2022)

Figure 06: Global Market Value Share, by Region (2022)

Figure 07: Global Market Value Share, by Product, 2023 and 2033

Figure 08: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 09: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 10: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 11: Global Market Attractiveness, by Product, 2023–2033

Figure 12: Global Market Value Share, by Application, 2023 and 2033

Figure 13: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 14: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 15: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 16: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 17: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,

Figure 18: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 19: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,

Figure 20: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 21: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 22: Global Market Attractiveness, by Application, 2023–2033

Figure 23: Global Market Value Share, by End-user, 2023 and 2033

Figure 24: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 25: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 26: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 27: Global Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 28: Global Market Attractiveness, by End-user, 2023–2033

Figure 29: Global Market Value Share, by Region, 2023 and 2033

Figure 30: Global Market Attractiveness, by Region, 2023–2033

Figure 31: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection

Figure 32: North America Market Value Share, by Country, 2023 and 2033

Figure 33: North America Market Attractiveness, by Country, 2023–2033

Figure 34: North America Market Value Share, by Product, 2023 and 2033

Figure 35: North America Market Attractiveness, by Product, 2023–2033

Figure 36: North America Market Value Share, by Application, 2023 and 2033

Figure 37: North America Market Attractiveness, by Application, 2023–2033

Figure 38: North America Market Value Share, by End-user, 2023 and 2033

Figure 39: North America Market Attractiveness, by End-user, 2023–2033

Figure 40: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 41: Europe Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 42: Europe Market Attractiveness, by Country/Sub-region, 2023–2033

Figure 43: Europe Market Value Share, by Product, 2023 and 2033

Figure 44: Europe Market Attractiveness, by Product, 2023–2033

Figure 45: Europe Market Value Share, by Application, 2023 and 2033

Figure 46: Europe Market Attractiveness, by Application, 2023–2033

Figure 47: Europe Market Value Share, by End-user, 2023 and 2033

Figure 48: Europe Market Attractiveness, by End-user, 2023–2033

Figure 49: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 50: Asia Pacific Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 51: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023–2033

Figure 52: Asia Pacific Market Value Share, by Product, 2023 and 2033

Figure 53: Asia Pacific Market Attractiveness, by Product, 2023–2033

Figure 54: Asia Pacific Market Value Share, by Application, 2023 and 2033

Figure 55: Asia Pacific Market Attractiveness, by Application, 2023–2033

Figure 56: Asia Pacific Market Value Share, by End-user, 2023 and 2033

Figure 57: Asia Pacific Market Attractiveness, by End-user, 2023–2033

Figure 58: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 59: Latin America Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 60: Latin America Market Attractiveness, by Country/Sub-region, 2023–2033

Figure 61: Latin America Market Value Share, by Product, 2023 and 2033

Figure 62: Latin America Market Attractiveness, by Product, 2023–2033

Figure 63: Latin America Market Value Share, by Application, 2023 and 2033

Figure 64: Latin America Market Attractiveness, by Application, 2023–2033

Figure 65: Latin America Market Value Share, by End-user, 2023 and 2033

Figure 66: Latin America Market Attractiveness, by End-user, 2023–2033

Figure 67: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection

Figure 68: Middle East & Africa Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 69: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2017– 2033

Figure 70: Middle East & Africa Market Value Share, by Product, 2023 and 2033

Figure 71: Middle East & Africa Market Attractiveness, by Product, 2023–2033

Figure 72: Middle East & Africa Market Value Share, by Application, 2023 and 2033

Figure 73: Middle East & Africa Market Attractiveness, by Application, 2023–2033

Figure 74: Middle East & Africa Market Value Share, by End-user, 2023 and 2033

Figure 75: Middle East & Africa Market Attractiveness, by End-user, 2023–2033

Figure 76: Global Market Share, by Company, 2022

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Chemiluminescence Immunoassay (CLIA) Analyzers Market

Schedule a Call

Copyright © Fact.MR All Rights Reserved

An initiative of Eminent Research and Advisory Services

Google translate